Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: growthvalue who wrote (24472)	8/13/1998 5:18:00 PM
From: Torben Noerup Nielsen	Respond to of 32384

>I think the lack of skepticism is a little unhealthy. I'm skeptical, but I just can't make the pieces fit. Sure, SRGN made lots of mistakes and in a lot of ways, they didn't know what they were doing. Lots of small startups don't because you are dealing with scientists becoming managers in a sink or swim fashion. But LGND has a seasoned team running things so I tend to give them a little more credit and assume they do know what they are doing. Hell, part of it is probably wishful thinking too :-( SRGN was really in bad shape. To a large extent, it was a university owned company and that is not a good thing to be from what I have seen. Cheers, Torben